We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

New data show infant gut microbiome maturation trajectories stratify risk of type 1 diabetes and early autoimmune activity. More...
22 Sep 2026
Image: cCMV screening is not universal in U.S. newborns, yet over 40% of children who develop related hearing loss initially pass newborn hearing screening, highlighting the need for broader approaches (Image Credit: iStock)

Expanded Newborn Screening Program Increases Detection of Congenital Cytomegalovirus

A system-wide newborn cCMV screening program using swab and urine tests boosts detection 2.5-fold and enables earlier care. More...
22 Sep 2026
Image

FDA Breakthrough-Designated Urine Panel Aims to Shorten Pathogen and Susceptibility Testing

A direct-from-specimen urine ID/AST panel received FDA Breakthrough status to support same-day organism identification and susceptibility testing. More...
22 Sep 2026
Image: Volcano plot of overrepresented genes in H10544. (Zhichen Zhu et al., Antimicrobial Agents and Chemotherapy (2026). DOI: 10.1128/aac.00506-26)

Genetic Studies Uncover Mechanisms Driving Drug Resistance in Superbugs

New findings map K. pneumoniae drug resistance, reveal trade-offs that restore last-line treatment sensitivity, and support targeted prevention. More...
22 Sep 2026
Image: Signatera uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

New findings for Natera's Signatera molecular residual disease (MRD) test were presented at the IASLC 2026 World Conference. More...
22 Sep 2026
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Siemens Healthineers and Novo have partnered to advance MASLD and MASH care through earlier assessment and broader access to noninvasive testing. More...
22 Sep 2026
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

New data show infant gut microbiome maturation trajectories stratify risk of type 1 diabetes and early autoimmune activity. More...
22 Sep 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
POC Immunoassay Analyzer
Procise DX
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Copyright © 2000-2026 Globetech Media. All rights reserved.